(Q34574542)

3 August 2017

title

Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population (English)

1 reference

3 August 2017

0 references

0 references

0 references

12

Mary-Claire King

0 references

Ronit Shiri-Sverdlov

object named as

Ronit Shiri-Sverdlov

7

0 references

Ephrat Levy-Lahad

object named as

Ephrat Levy-Lahad

14

0 references

Avi Orr-Urtreger

5

object named as

Avi Orr-Urtreger

1 reference

3 August 2017

10

Mordechai Shohat

1 reference

3 August 2017

Sharon Simchoni

1

1 reference

3 August 2017

Eitan Friedman

2

1 reference

3 August 2017

Bella Kaufman

3

1 reference

3 August 2017

Ruth Gershoni-Baruch

4

1 reference

3 August 2017

Inbal Kedar-Barnes

6

1 reference

3 August 2017

Efrat Dagan

8

1 reference

3 August 2017

Sigal Tsabari

9

1 reference

3 August 2017

Raphael Catane

11

1 reference

3 August 2017

Amnon Lahad

13

1 reference

3 August 2017

language of work or name

English

0 references

publication date

28 February 2006

1 reference

Proceedings of the National Academy of Sciences of the United States of America

3 August 2017

published in

1 reference

3 August 2017

volume

103

1 reference

3 August 2017

issue

10

1 reference

3 August 2017

page(s)

3770-3774

1 reference

Prevention and management of hereditary breast cancer

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Modifiers of risk of hereditary breast and ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

CAG and GGC repeat polymorphisms in the androgen receptor gene and breast cancer susceptibility in BRCA1/2 carriers and non-carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Modification of BRCA1-associated breast cancer risk by the polymorphic androgen-receptor CAG repeat

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.

7 July 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0511301103

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0511301103

Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele.

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0511301103

Polyglutamine repeat length in theAIB1 gene modifies breast cancer susceptibility inBRCA1 carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0511301103

Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1450152

BRCA1 and BRCA2 founder mutations in patients with bilateral breast cancer

27 October 2018

1 reference

12 December 2020

Risk models for familial ovarian and breast cancer

1 reference

12 December 2020

Mutational analyses ofBRCA1 andBRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer

1 reference

12 December 2020

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers

1 reference

12 December 2020

Androgen receptor CAG repeat length in Jewish Israeli women who are BRCA1/2 mutation carriers: association with breast/ovarian cancer phenotype

1 reference

12 December 2020

Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus

1 reference

12 December 2020

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.0511301103

1 reference

3 August 2017

0 references

1 reference

3 August 2017

1 reference